The Juncker Commission is walking on eggshells to fulfil 2017 commitments on endocrine disruptors. After the obstacles encountered in defining the criteria, it limited itself, on Wednesday 7 November, to launching a review of the current legislation to assess the relevance of a common framework.
The Communication, which is only 12 pages long, responds to the commitment made in 2017 to work on a new strategy to "reduce as much as possible the exposure of EU citizens to endocrine...